Add time:08/23/2019 Source:sciencedirect.com
The objective of this study was to investigate the anticancer activity of caffeate derivatives in human cancer cells. Our results demonstrate that caffeate derivatives decreased the population growth of COLO 205, assessed using the MTT assay. However, caffeate derivatives, at the concentrations used in this study (0–250 μM) did not affect the viability of HepG2, Huh7, PLC5, and SK-Hep-1 cells. Flow cytometric analysis of COLO 205 cells exposed to decyl caffeate showed that the number of apoptotic cells increased in a time- and dose-dependent manner. Western blot analysis revealed that decyl caffeate stimulated an increase in protein expression levels of p53, Fas, FasL, AIF, and Apaf-1. Additionally, treatment with decyl caffeate changed the expression levels of Bcl-2 family members and subsequently induced the activation of caspase-12, caspase-9, and caspase-3, which was followed by cleavage of PARP. Our findings highlight the chemopreventive potential of decyl caffeate.
We also recommend Trading Suppliers and Manufacturers of Phenethyl caffeate (cas 104594-70-9). Pls Click Website Link as below: cas 104594-70-9 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View